124 related articles for article (PubMed ID: 10396687)
21. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
22. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
23. [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae in the Kinki District].
Otsuki M; Nishino T
Kansenshogaku Zasshi; 2000 Aug; 74(8):658-63. PubMed ID: 11019514
[TBL] [Abstract][Full Text] [Related]
24. Detection of vancomycin-resistant enterococci from faecal samples of Iberian wolf and Iberian lynx, including Enterococcus faecium strains of CC17 and the new singleton ST573.
Gonçalves A; Igrejas G; Radhouani H; López M; Guerra A; Petrucci-Fonseca F; Alcaide E; Zorrilla I; Serra R; Torres C; Poeta P
Sci Total Environ; 2011 Dec; 410-411():266-8. PubMed ID: 22018960
[TBL] [Abstract][Full Text] [Related]
25. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
26. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
[TBL] [Abstract][Full Text] [Related]
27. Emergence and epidemiology of vancomycin-resistant enterococci in Australia.
Bell J; Turnidge J; Coombs G; O'Brien F
Commun Dis Intell; 1998 Oct; 22(11):249-52. PubMed ID: 9823687
[TBL] [Abstract][Full Text] [Related]
28. [Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penisillin-resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district].
Sunada A; Asari S
Kansenshogaku Zasshi; 2003 May; 77(5):331-9. PubMed ID: 12806929
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
30. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
Socha AM; LaPlante KL; Rowley DC
Bioorg Med Chem; 2006 Dec; 14(24):8446-54. PubMed ID: 16979896
[TBL] [Abstract][Full Text] [Related]
31. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
33. Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.
Robredo B; Singh KV; Torres C; Murray BE
Microb Drug Resist; 2000; 6(4):305-11. PubMed ID: 11272259
[TBL] [Abstract][Full Text] [Related]
34. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
[TBL] [Abstract][Full Text] [Related]
35. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
[TBL] [Abstract][Full Text] [Related]
36. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Dowzicky MJ; Chmelařová E
Int J Antimicrob Agents; 2011 Jun; 37(6):562-6. PubMed ID: 21497066
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
[TBL] [Abstract][Full Text] [Related]
38. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
Dowzicky MJ
Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
[TBL] [Abstract][Full Text] [Related]
40. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
